Experienced in oligonucleotide nano-formulation for cancer immunotherapy (polymers, LNPs, nano-emulsions) and vast physico-chemical and biological (in vitro) characterization - employing orthogonal technique approach (DLS, NTA, EM, AF4-MALS, SEC-MALS, SAXs, besides others). Quality by Design (QbD) approach and regulatory knowledge on nanomedicine formulations.
University of Geneva
Geneva, Genève, Switzerland
Prize for the Best Life Science Project
Innosuisse